Invesco Biotechnology & Genome ETFInvesco Biotechnology & Genome ETFInvesco Biotechnology & Genome ETF

Invesco Biotechnology & Genome ETF

No trades
See on Supercharts

Invesco Biotechnology & Genome ETF holdings


As of July 16, 2025
Symbol
Weight %
Shares
Market value
I
ILMNIllumina, Inc.
5.54%
‪‪131.53 K‬‬
‪‪12.75 M‬‬USD
A
ALNYAlnylam Pharmaceuticals, Inc
5.24%
‪‪37.40 K‬‬
‪‪12.07 M‬‬USD
R
RPRXRoyalty Pharma Plc Class A
5.13%
‪‪331.91 K‬‬
‪‪11.82 M‬‬USD
A
AMGNAmgen Inc.
5.04%
‪‪38.83 K‬‬
‪‪11.61 M‬‬USD
V
VRTXVertex Pharmaceuticals Incorporated
4.96%
‪‪24.33 K‬‬
‪‪11.42 M‬‬USD
G
GILDGilead Sciences, Inc.
4.74%
‪‪99.46 K‬‬
‪‪10.93 M‬‬USD
B
BMRNBioMarin Pharmaceutical Inc.
4.73%
‪‪186.72 K‬‬
‪‪10.90 M‬‬USD
U
UTHRUnited Therapeutics Corporation
4.46%
‪‪34.46 K‬‬
‪‪10.28 M‬‬USD
A
AVXLAnavex Life Sciences Corp.
3.93%
‪‪803.02 K‬‬
‪‪9.04 M‬‬USD
B
BPMCBlueprint Medicines Corp.
3.32%
‪‪59.15 K‬‬
‪‪7.65 M‬‬USD
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.